Results 91 to 100 of about 8,517,970 (127)
Objectives: This study reviewed the status of adverse event (AE) reporting in VigiAccess using anti-obesity agents as examples and explored the possibility of its use and future challenges.Methods: AE reports related to some representative drugs among herbal medicines (HMs), complex HM prescriptions, ingredients of supplements, and over-the-counter and
openaire +1 more source
Monographs on selected medicinal plants. Volume IV
WHO published Volume 1 of the WHO monographs on selected medicinal plants, containing 28 monographs, in 1999, Volume 2 including 30 monographs in 2002, and the third volume presenting 31 monographs in 2007.
World Health Organization (WHO)
core +1 more source
Quality control methods for herbal materials [PDF]
WHO published Quality control methods for medicinal plant materials in 1998, in order to support WHO Member States in establishing quality standards and specifications for herbal materials, within the overall context of quality assurance and control ...
World Health Organization (WHO)
core
Objectives: This study was aimed to review the global status of adverse event (AE) reports and the characteristics of the reported AEs of plants managed as herbal medicines (HMs) with toxic precautions in Korea.Methods: This is a cross-sectional quantitative study that analyzed information available through VigiAccess, a website that provides ...
openaire +1 more source
Global health expectancy research among older people
WHO definition of ageing or old age, page 10106 ...
WHO Centre for Health Development (Kobe, Japan)
core
A glossary of terms for community health care and services for older persons
WHO/WKC/Tech.Ser./04.2109 ...
WHO Centre for Health Development (Kobe, Japan)
core
Who\u27s Who Biography of Henry Cherry [PDF]
Who\u27s Who biographical entry for Henry Cherry.https://digitalcommons.wku.edu/exhibit_2015/1022/thumbnail ...
Who\u27s Who
core
Post-marketing safety assessment of tetrandrine based on the WHO-VigiAccess database. [PDF]
Zhong Y, Tan X, Fang C.
europepmc +1 more source
Pregabalin-associated adverse drug reactions: A real-world pharmacovigilance study using WHO-VigiAccess. [PDF]
Alshehri FS +5 more
europepmc +1 more source

